Records containing: Multiple Sclerosis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2022-01-18The Influence of Cognitive Behavioral Therapy on Fatigue, Cognition and Inflammatory Biomarkers in Multiple Sclerosis Patients
-
CLINICAL_TRIALS study record update · 2022-01-14Long-term, Prospective,Multinational, Parallel-cohort Study Monitoring Safety in Patients With MS Newly Started With Fingolimod Once Daily or Treated With Another Approved Disease-modifying Therapy
-
CLINICAL_TRIALS study record update · 2022-01-13Investigation of the Effects of Selective Exercise Training on Muscle Architecture, Balance, Function and Fatigue in Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2022-01-13A Prospective Biomarker Study in Active Secondary Progressive Multiple Sclerosis (SPMS)Subjects Treated With Cladribine Tablets
-
CLINICAL_TRIALS study record update · 2022-01-13Nature of the Link Between Executive Functions and Theory of Mind in Multiple Sclerosis
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2022-01-11Neurology Inpatient Clinical Education Trial
-
CLINICAL_TRIALS study record update · 2022-01-11An Open-Label, Single-Arm Phase IV Study To Assess Ocrelizumab Efficacy, Safety, And Impact On Patient Reported Outcomes (PROS) In Patients With Active Relapsing Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2022-01-06Examining the Effects of Physical Activity Promotion, Fatigue Management Education, and Social Support Using a Telehealth Intervention Approach Among Adults With Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2022-01-03Adherence to Mediterranean Diet and Cardiovascular Health in Multiple Sclerosis Female Patients: a Case Control Study
-
CLINICAL_TRIALS study record update · 2021-12-21A 3-arm, Multicenter, Double-blind, Placebo-controlled, Randomized Study to Assess the Efficacy and Safety of ADS-5102 Amantadine Extended Release Capsules in Multiple Sclerosis Patients With Walking Impairment
-
CLINICAL_TRIALS study record update · 2021-12-16Impact of Fingolimod Adherence on Outcomes
-
CLINICAL_TRIALS study record update · 2021-12-16Transcranial Direct Current Stimulation (tDCS) for the Management of Multiple Sclerosis Related Fatigue
-
CLINICAL_TRIALS study record update · 2021-12-02T Cell/B Cell Collaboration in Multiple Sclerosis: Exploring an Intimate Relationship
-
CLINICAL_TRIALS study record update · 2021-11-30Individualized Physiotherapy and Activity Coaching for Multiple Sclerosis (IPAC-MS): A Randomised Controlled Trial
-
CLINICAL_TRIALS study record update · 2021-11-26A Pilot Study Evaluating the Feasibility of A Mobile Application to Collect Clinical, Magnetic Resonance Imaging Information and Genetic Data in Participants With Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2021-11-22A Phase 2, Double-blind, Randomized, Placebo-controlled, Four-arm, Multicenter, Dose-finding Study to Assess the Safety and Efficacy of Three Dose Levels of AVP-923 (Dextromethorphan/Quinidine) in the Treatment of Central Neuropathic Pain in Patients With Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2021-11-19Barriers to Physical Activity in People With MS (Barrieren für körperliche Aktivität Bei MS-Betroffenen - BarKA-MS) - A Longitudinal Observational Study
-
CLINICAL_TRIALS study record update · 2021-11-16Phase IV, Rater-blinded, Randomized Study, Comparing 250 mg of Betaseron With 20 mg of Copaxone in Patients With the Relapsing-remitting(RR) or CIS Forms of ms Using 3 Tesla(3T) Magnetic Resonance Imaging (MRI) With Triple-dose Gadolinium
-
CLINICAL_TRIALS study record update · 2021-11-09Diagnosic and Pronostic Values of Kappa and Lambda Free Light Chains in Central Nervous System Inflammatory Diseases
-
CLINICAL_TRIALS study record update · 2021-11-03A Phase I, Randomized, Double-Blind, Placebo-Controlled, Safety, Tolerability and Pharmacokinetic Study of Escalating Single and Multiple Doses of PIPE-307 and Food Effect in Normal Healthy Volunteers
-
CLINICAL_TRIALS study record update · 2021-11-02A Multinational, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled Study, to Evaluate the Safety, Tolerability and Efficacy of Daily Oral Administration of Laquinimod 0.6 mg in Subjects With RRMS
-
CLINICAL_TRIALS study record update · 2021-10-22Feasibility Study of Tolerogenic Fibroblasts in Patients With Refractory Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2021-10-14Trial of the Efficacy and Safety of Pathogenetic Therapy of Multiple Sclerosis and Other Autoimmune Diseases Using Intrathecal Rituximab
-
CLINICAL_TRIALS study record update · 2021-10-14Central and Peripheral Nervous System Changes as Markers of Disease Progression in Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2021-10-13A Multicentre Observational Study for the Evaluation in Clinical Practice of the Initial Diagnostic-therapeutic Path of Urinary Disorders in Multiple Sclerosis